AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Vrigaba-M Tablet

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Gabapentin (300mg) + Methylcobalamin (500mcg)

Overview Vrigaba-M Tablet

Neuropathic pain is treated with the combined medication, Vrigaba-M Tablet. This medication reduces pain by regulating nerve cell calcium channel activity. Administered orally, Vrigaba-M Tablet may be taken with or without food, ideally before sleep. Consistent daily dosing maintains therapeutic blood levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even if symptoms improve. Abrupt cessation should only occur under medical supervision. Common side effects include nausea, peripheral swelling, unsteadiness, blurred vision, fever, and involuntary eye movements (nystagmus). Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the drug's effects are known. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose pregnancy, pregnancy plans, or breastfeeding before commencing treatment. While generally compatible with other medications, certain drugs (including antacids and alcohol) can alter its efficacy and increase adverse effects.

Uses of Vrigaba-M Tablet

Managing neuropathic pain

Major Benefits of Vrigaba-M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vrigaba-M Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Vrigaba-M Tablet:

  • Dizziness
  • Sleepiness
  • Tiredness
  • Uncoordinated body movements

How to use Vrigaba-M Tablet:

Your physician will determine the correct dosage and treatment length for this medication. Ingest the Vrigaba-M Tablet whole; do not break, crush, or chew it. This medication can be administered with or without food, however, consistent timing is recommended.

How Vrigaba-M Tablet works:

Vrigaba-M Tablets contain Gabapentin and Methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta calcium channel modulator, reduces pain signals by altering nerve cell calcium activity. Methylcobalamin, a B vitamin, supports myelin production, protecting and repairing nerve fibers. This combined action provides relief from nerve damage-induced pain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Vrigaba-M tablets and alcohol may induce significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vrigaba-M Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Vrigaba-M tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, newborns should be observed for any unusual drowsiness or increased weight.

DrivingDrivingUNSAFE

Taking Vrigaba-M Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Vrigaba-M tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Vrigaba-M Tablet's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Vrigaba-M Tablet :

Should you forget a Vrigaba-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vrigaba-M Tablet

LabelValue
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System

FAQs on Vrigaba-M Tablet

Vrigaba-M Tablets combine gabapentin and methylcobalamin to treat nerve pain (peripheral neuropathy). It works by promoting nerve regeneration and reducing pain signals.
Peripheral neuropathy is damage to peripheral nerves—the nerves in your extremities, like your toes and fingertips. These nerves transmit signals between your brain and spinal cord (central nervous system) and the rest of your body. Damage disrupts these signals, impairing nerve function.
No, continue taking Vrigaba-M tablets for the entire prescribed duration. Complete healing of the nerves may take longer than the initial symptom improvement.
Vrigaba-M Tablet commonly causes drowsiness. Avoid driving, operating machinery, or other activities requiring alertness. Alcohol should be avoided while taking Vrigaba-M Tablet due to the risk of increased drowsiness and potential accidents.
Exceeding the recommended Vrigaba-M Tablet dosage increases the risk of side effects and toxicity. For worsening symptoms unrelieved by the prescribed dose, consult your doctor.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Vrigaba-M Tablet
89
MRP 103
13% off